Hydrogels comprising cell adhesive peptides and methods of use thereof
US-2024376438-A1 · Nov 14, 2024 · US
US10968346B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10968346-B2 |
| Application number | US-201916299835-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2019 |
| Priority date | Sep 13, 2016 |
| Publication date | Apr 6, 2021 |
| Grant date | Apr 6, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method of manufacturing a polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan according to the present invention comprises dissolving fucoidan in glacial acetic acid as a solvent to obtain fucoidan-glacial acetic acid solution, mixing polycaprolactone with the fucoidan-glacial acetic acid solution to obtain a polycaprolactone-mixed solution, and manufacturing a nanostructure from the polycaprolactone-mixed solution by an electrospinning method. Therefore, a polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan manufactured by the method according to the present invention exhibits characteristics of preventing fucoidan from being released from nanofibers by uniformly distributing fucoidan in the polycaprolactone nanostructure. Accordingly, the fucoidan-containing polycaprolactone nanostructure exhibits an effect capable of controlling cell activity while culturing adhered cells by facilitating adhesion of various types of cells.
Opening claim text (preview).
What is claimed is: 1. A method of manufacturing a polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan, the method comprising the steps of: dissolving fucoidan in distilled water to obtain fucoidan-dissolved distilled water, and mixing the fucoidan-dissolved distilled water with a glacial acetic acid solution to obtain a fucoidan-glacial acetic acid solution; dissolving polycaprolactone in the fucoidan-glacial acetic acid solution to obtain a solution; stirring the solution at a temperature of 35 to 40° C. for 12 hours to obtain a resulting solution; and manufacturing a nanostructure from the solution by an electrospinning method, wherein, the fucoidan-glacial acetic acid solution obtained by the step of mixing the fucoidan-dissolved distilled water with a glacial acetic acid solution comprises 0.5 to 1 mg/ml of fucoidan. 2. The method of claim 1 , wherein the step of manufacturing a nanostructure from the solution by an electrospinning method comprises manufacturing a nanostructure from the solution by an electrospinning method at a voltage of 8 to 10 KV and a spinning speed of 8 to 10 μg/min. 3. A polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan manufactured according to the method of claim 1 . 4. A polycaprolactone nanostructure with improved cell adhesive ability containing fucoidan manufactured according to the method of claim 2 .
characterised by the electro-spinning apparatus · CPC title
Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides · CPC title
from polymer solutions · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.